DIVISLAB's weekly performance was disappointing, with a return of -2.81%, outperforming only DRREDDY and SUNPHARMA among its peers. The stock's volatility was high at 37.79%, indicating significant price fluctuations. Despite being less volatile than DRREDDY, DIVISLAB's Sharpe Ratio was still negative, suggesting that the returns did not justify the risk taken. Overall, the stock's performance was mediocre, with a relatively high level of risk.

[Volatility: 37.79%]